Keyphrases
Daytime Urinary Incontinence
31%
Genetic Risk
31%
Genome-wide Association Study
31%
Voiding Diary
31%
Primary Nocturnal Enuresis
31%
Novel Prediction
31%
Prediction Tool
31%
Desmopressin (DDAVP)
31%
International multicenter Study
31%
Void Volume
23%
Nocturnal Polyuria
23%
Odds Ratio
22%
Treatment Selection
15%
Risk Ratio
15%
Heritability
9%
Genetic Correlation
9%
Chromosome 6
9%
Selection Risk
7%
Enuresis Alarm
7%
Demographic Variables
7%
Urine Bladder
7%
Demographic Information
7%
Clinical Variables
7%
Group Treatment
7%
Pathogenic Factors
7%
Treatment Choice
7%
Clinically Significant
7%
Receiver Operating Characteristic Curve
7%
Predictive Value
7%
Response Predictors
7%
Clinical Trial Registry
7%
Statistical Analysis
7%
Individualized Treatment
7%
Clinical Information
7%
Prediction Model
7%
Nave
7%
Urine Volume
7%
Reservoir Function
7%
Medicine and Dentistry
Nocturnal Enuresis
100%
Incontinence
40%
Bladder
39%
Polyuria
37%
Urination
36%
Genome Wide Association Study
35%
Transcutaneous Electrical Nerve Stimulation
31%
Placebo-Controlled Study
31%
Diurnal Enuresis
31%
Genetic Risk
31%
Odds Ratio
22%
Desmopressin
17%
Heritability
13%
Enuresis
12%
Chromosome 6
9%
Genetic Correlation
9%
Bladder Capacity
9%
Genetic Variability
7%
Group Therapy
7%
Clinical Trial
7%
Biochemistry, Genetics and Molecular Biology
Genetic Divergence
44%
Genome-Wide Association Study
38%
Genetics
31%
Genetic Risk
31%
Chromosome 6
31%
Genetic Correlation
31%
Single-Nucleotide Polymorphism
15%
Gene Linkage Disequilibrium
15%
Muscle Contraction
15%
Polygenic Score
15%
Gene Linkage
6%
Twin Study
6%
Endothelin
6%
Candidate Gene
6%